Biodefense Market Research 2020-2024 - Featuring Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., Among Others to Contribute to the Market Growth

Technavio has announced its latest market research report titled Global Biodefense Market 2020-2024 (Graphic: Business Wire)

LONDON--()--The biodefense market is poised to grow by USD 3.22 bn during 2020-2024, progressing at a CAGR of over 8% during the forecast period.
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the biodefense market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by growing threat of bioterrorism.

The biodefense market analysis includes application segment and geography landscape. This study identifies the government initiatives as one of the prime reasons driving the biodefense market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The biodefense market covers the following areas:

Biodefense Market Sizing
Biodefense Market Forecast
Biodefense Market Analysis

Companies Mentioned

  • Alexeter Technologies LLC
  • Alnylam Pharmaceuticals Inc.
  • Altimmune Inc.
  • ANP Technologies Inc.
  • Bavarian Nordic AS
  • Cleveland BioLabs Inc.
  • Elusys Therapeutics Inc.
  • Emergent BioSolutions Inc.
  • General Dynamics Corp.
  • GlaxoSmithKline Plc

     

Related Reports on Health Care Include:

  • Microbial Identification Market by End-user and Geography - Forecast and Analysis 2020-2024 - The microbial identification market size has the potential to grow by USD 991.90 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes
  • Laser-Assisted In-Situ Keratomileusis Surgery Market by Technology, End-user, and Geography - Forecast and Analysis 2020-2024 - The laser-assisted in-situ keratomileusis (LASIK) surgery market size has the potential to grow by USD 375.04 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Anthrax - Market size and forecast 2019-2024
  • Smallpox - Market size and forecast 2019-2024
  • Botulism - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Alexeter Technologies LLC
  • Alnylam Pharmaceuticals Inc.
  • Altimmune Inc.
  • ANP Technologies Inc.
  • Bavarian Nordic AS
  • Cleveland BioLabs Inc.
  • Elusys Therapeutics Inc.
  • Emergent BioSolutions Inc.
  • General Dynamics Corp.
  • GlaxoSmithKline Plc

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Release Summary

The Biodefense Market will grow by USD 3.22 bn during 2020-2024

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/